Denmark Blood Donors are Now Being Re-examined for Coronavirus Infection
Survey:
Epi surveillance
Blood tests
Dataset Records for Blood tests
Displaying 101 - 150 of 1386
Brazil - Rio Grande Do Sol Epicovid19 Relevance Study 2020
Survey:
Epi surveillance
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
GHDx Entry last modified on: Mar 14, 2022
Estonia COVID-19 Coronavirus prevalence study
Koroonaviiruse levimuse uuring "Covid-19 aktiivne seire"
Survey:
Epi surveillance
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021
COVID-19 Public Seroprevalence Report April 2020 to January 2021
Epi surveillance:
Nationally representative
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint
GHDx Entry last modified on: Mar 14, 2022
Germany - Saarland antibody study on coronavirus infection completed: Institute for Virology at Saarland University Hospital presents results
GHDx Entry last modified on: Feb 10, 2022
Canada COVID-19 Seroprevalence Report - January 12, 2021
COVID-19 Seroprevalence Report January 12, 2021 - Report #4: November 2020 Survey
Canada COVID-19 Seroprevalence Report - December 18, 2020
COVID-19 Seroprevalence Report December 18, 2020 - Report #3: October 2020 Survey
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
GHDx Entry last modified on: Mar 14, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?
GHDx Entry last modified on: Mar 14, 2022
Detection of Antibodies After Review of Covid-19 in Blood Donors (Sub-report 2)
Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2)
Survey:
Epi surveillance
Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study
GHDx Entry last modified on: Mar 14, 2022
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
GHDx Entry last modified on: Mar 14, 2022
France COVID-19 Epidemic Monitoring Dashboard
Tableau de bord COVID-19 Suivi de l’épidémie de COVID-19 en France
Belgium Prevalence of anti-SARS-CoV-2 antibodies (IgG) among blood donors
Belgium COVID-19 Studies, Seroprevalence in Blood Donors
France Covid-19 Information - Average number of new daily hospitalizations
Informations Covid-19 - Nombre moyen de nouvelles hospitalisations quotidiennes
India COVID-19 Official Government of India updates - Twitter
GHDx Entry last modified on: May 12, 2022
Switzerland COVID-19 PCR Antigen Tests by Region 2020
Daily record timelines by geoRegion and test type (pcr/antigen) for testsonen
Epi surveillance:
Subnationally representative
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Mar 14, 2022
The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study. Preprint
GHDx Entry last modified on: May 12, 2022
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
GHDx Entry last modified on: Feb 10, 2022
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises
GHDx Entry last modified on: Mar 14, 2022
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations. Preprint
GHDx Entry last modified on: Apr 8, 2022
COVID-Inconfidentes - SARS-CoV-2 seroprevalence in two Brazilian urban areas during the pandemic first wave: study protocol and initial results. Preprint
GHDx Entry last modified on: Mar 14, 2022
Canada - Daily Epidemiologic Summary of COVID-19 in Ontario 2020
Epidemiologic Summary COVID-19 in Ontario
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
GHDx Entry last modified on: May 12, 2022
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Increased Mask Use and Fewer Gatherings Associated with Lower SARS-CoV-2 Seropositivity Among Young School-Age Children. Preprint
GHDx Entry last modified on: Mar 14, 2022
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany
GHDx Entry last modified on: Jun 17, 2021
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
GHDx Entry last modified on: May 12, 2022
Dynamics of seroconversion of anti-SARS-CoV-2 IgG antibodies in the Czech unvaccinated population: nationwide prospective seroconversion (PROSECO) study. Preprint
GHDx Entry last modified on: May 12, 2022
Subscribe